These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14624703)

  • 21. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
    Nunes EV; Quitkin FM; Donovan SJ; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath PJ; Woody G
    Arch Gen Psychiatry; 1998 Feb; 55(2):153-60. PubMed ID: 9477929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
    Ling W; Casadonte P; Bigelow G; Kampman KM; Patkar A; Bailey GL; Rosenthal RN; Beebe KL
    JAMA; 2010 Oct; 304(14):1576-83. PubMed ID: 20940383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study.
    Corwin RL; Boan J; Peters KF; Ulbrecht JS
    Behav Pharmacol; 2012 Sep; 23(5-6):616-25. PubMed ID: 22854310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baclofen: a new drug for the treatment of alcohol dependence.
    Addolorato G; Leggio L; Agabio R; Colombo G; Gasbarrini G
    Int J Clin Pract; 2006 Aug; 60(8):1003-8. PubMed ID: 16893442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.
    Leggio L; Garbutt JC; Addolorato G
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):33-44. PubMed ID: 20201813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
    Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
    J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial.
    Xu D; Qu C; Meng H; Ren J; Zhu Y; Min Z; Kong Y
    BJU Int; 2007 Sep; 100(3):588-92. PubMed ID: 17511770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
    Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
    Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
    Krupitsky EM; Blokhina EA; Zvartau EE; Verbitskaya VE; Bushara EM; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Burakov AM; Masalov DV; Romanova TN; Grininko AY; Sinha R; Kosten T
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):39-46. PubMed ID: 26525620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
    Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
    Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
    Addolorato G; Leggio L
    Curr Pharm Des; 2010; 16(19):2113-7. PubMed ID: 20482507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.
    Heinzerling KG; Shoptaw S; Peck JA; Yang X; Liu J; Roll J; Ling W
    Drug Alcohol Depend; 2006 Dec; 85(3):177-84. PubMed ID: 16740370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome.
    Girish K; Vikram Reddy K; Pandit LV; Pundarikaksha HP; Vijendra R; Vasundara K; Manjunatha R; Nagraj M; Shruthi R
    Biomed J; 2016 Feb; 39(1):72-80. PubMed ID: 27105601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.